Navigation Links
Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009
Date:11/9/2009

SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that Dr. David Loury, Vice President, Preclinical Development will provide an overview of the company and its clinical programs at Merriman Curhan Ford's 6th Annual Investor Summit.

The Pharmacyclics presentation will take place at the Sofitel Hotel in New York on Tuesday, November 10, 2009 at 9:40 a.m. ET

There will be a live webcast of the presentation, which will be accessible through a link posted on the investor relations / events & webcasts section of the PCYC website, please go to http://ir.pharmacyclics.com/events.cfm.

About Pharmacyclics

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is Pharmacyclics' business strategy to establish collaborations with large pharmaceutical and biotechnology companies for the purpose of generating present and future income in exchange f
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--RegadoBiosciences,aprivat...captamerswithactivecontrolagents,announcedthatDavi...perJaffray21stAnnualHealthCareConferenceattheNewYo...illbegivenat1:10pm(EST)onTuesday,December1andwilli...ontheleaddevelopmentprogram,theanticoagulantsystem...
(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... MammographyEquipment-AGlobalMarketPerspective ...graphy-Equipment---A-Global-Market-Perspective.htm...izedaswellasdevelopingnationsisaprincipalfactorinf...latingawarenessaboutbreastcancerhasallowedwomentoc...
(Date:11/25/2009)...,Nov.25/PRNewswire/--AccordingtoMillenniumResearch...rketintelligence,thenearly$3billionUSmarketfortrau...henextfiveyearsdespitetherecenteconomicslowdown.MR...tthismarketwillremainhighlydynamicoverthenextfivey...npreviouslyunderservedsegmentsofthetraumafixationm...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Indiana University receives NIH grant to improve health care in East Africa 61442 1Indiana University receives NIH grant to improve health care in East Africa 61442 2Indiana University receives NIH grant to improve health care in East Africa 61442 3Scientists guide immune cells with light and microparticles 10745 1Scientists guide immune cells with light and microparticles 10745 2New research provides insights into potential ecological costs and cobenefits of REDD 10742 1New research provides insights into potential ecological costs and cobenefits of REDD 10742 2New research provides insights into potential ecological costs and cobenefits of REDD 10742 3
...Annals of Surgery, MELBOURNE, Australia, Nov. 21 ...) Adjustable Gastric Banding System to lose weight... compared to obese people,who were not offered any...ings published in the December issue of the Annals...ed in June 2001 by the U.S. Food & Drug,Administra...
... People to Do Something Radical,and Simple to Figh...ok out for the Kick Me,sign. It,s back on the back..., an action-based initiative implemented by Popula... the launch of the 2007 ,Kick Me,campaign. The ,Ki...it into,a powerful tool to communicate facts, star...
Other Medicine Technology:LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity 2LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity 3LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity 4YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country 2YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country 3
(Date:11/25/2009)...hanksgivingmealswillbedeliveredtoapproximately1,00...FaithInAction/VolunteerActionforAging,aprogramoper...hPlan.Formorethan17yearstheseorganizationshavegath...ealstoseniorsinneedinLongBeach,Lakewood,SignalHill..., "Ourwarmholidaymealsaredeliveredtopeoplewhohave...
(Date:11/25/2009)...e/--TheBlackAIDSInstituterecentlyheldBoardofDirect...,, ThenewBoardMembersareahighlydiversegroupofle...ernmenthealthprograms,editorial,andbusinessentrepr...lbackgroundsincludingbothheterosexualandgayBlackme...ingmultipleagegroups. ,, (Photo: http://www.new...
(Date:11/25/2009)...ndPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,No...BipolarFoundationandtheMedicAlertFoundationreceive...,whichisnowbeingwidelyacceptedasapreventivehealthc...larFoundationreceivedaproclamationofendorsementvia...sianaMitchLandrieu.TheNationalBipolarFoundationsta...
(Date:11/25/2009)...ically significant survival benefit from adjuvant ...ER)-positive tumors had high levels of phosphoryla... according to a brief communication published onli...cer Institute . , Approximately 50% of breast ca...tudies have shown that ER-alpha S118-P is required...
(Date:11/25/2009)...imple question has been the focus of intense resea...ates High Blood Pressure in Mice & Men, Does stre...has been the focus of intense research for many ye...blished a link between a novel gene, phosducin, an... well as humans. The studies were directed by scie...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
... a recent study conducted by researchers at Wake F...gues show that cognitive functioning abilities dro...h type 2 diabetes. , The study appears in this mo...rial (ACCORD), found a statistically significant i...
...French . , Montreal, February 11th, 2009 - The ...nt on the nutrients the tumours receive through th...ch Institute of the McGill University Health Centr... stimulate the growth of the blood vessels that fe...
...rld,s first phase one FDA-approved clinical trial ...ase will be conducted by a team of University of ...he first time, patients with advanced heart diseas...ent,s own cardiac tissue. During surgery, a small ...
... Abbott ( NYSE: ABT ),today announced it received...nistration (FDA) for its new, compact hematology i...N Emerald will expand the company,s hematology,pla...ries and clinics continue to seek,greater efficien...
...ges Prevention Through Screenings , ...-- What better time than February, National Cancer...r health is in their own hands? ZocDoc, the servic... month. Now more than ever, New Yorkers are able t...
...ves better predictor than PSA, study says , ...g for changes in the number of circulating tumor c...ostate cancer patients, survival and response to t...ors such as changes in levels of prostate-specific...
Other Medicine News:Health News:Higher blood sugar levels linked to lower brain function in diabetics, study shows 2Health News:Innovative method to starve tumors 2Health News:World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 3Health News:ZocDoc Joins the Fight Against Cancer 2Health News:Levels of Circulating Tumor Cells Could Predict Prostate Cancer Outcome 2
...matology control, offers complete assay values for...ith the Coulter GENS, STKS, MAXM and HmX. This uni...y closed-vial stability and is available in low, n...al is compatible with all cassette systems. Barcod...
Antelys Peek Lumbar Technologies
D-SPECT Cardiac Imaging System
Placemark
Medicine Products: